- Dawson DA, Grant
BF, Li TK. Quantifying the risks associated with exceeding recommended drinking
limits. Alcohol Clin Exp Res. 29(5):902-908, 2005.
- U.S. Surgeon General releases advisory on alcohol use in pregnancy [press release]. Washington, DC: U.S. Department of Health and Human Services; February 21, 2005. Available at https://wayback.archive-it.org/3926/20140421162517/http://www. surgeongeneral.gov/news/2005/02/sg02222005.html
Institute on Alcohol Abuse and Alcoholism. Unpublished data from the 2001-2002
National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationwide
survey of 43,093 U.S. adults aged 18 or older. 2004.
J, Room R, Graham K, Monteiro M, Gmel G, Sempos CT. The relationship of average
volume of alcohol consumption and patterns of drinking to burden of disease: An
overview. Addiction. 98(9):1209-1228, 2003.
EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in
the United States. N Engl J Med. 348(26):2635-2645, 2003.
PM, Thomas SE, Mallin R. Patient attitudes towards self-report and biomarker alcohol
screening by primary care physicians. Alcohol Alcohol. 41(3):306-310,
EC, Kivlahan DR, Saitz R, et al. Readiness to change in primary care patients
who screened positive for alcohol misuse. Ann Fam Med. 4(3):213-220,
MF, Mundt MP, French MT, Manwell LB, Staauffacher EA, Barry KL. Brief physician
advice for problem drinkers: Long-term efficacy and cost-benefit analysis. Alcohol
Clin Exp Res. 26(1):36-43, 2002.
ML, Olson DH. A randomized trial of integrated outpatient treatment for medically
ill alcoholic men. Arch Intern Med. 13;159(16):1946-1952, 1999.
CS, Weiss DG, Groszmann R, Paronetto F, Schenker S, for the Veterans Affairs Cooperative
Study 391 Group. II. Veterans Affairs cooperative study of polyenylphosphatidylcholine
in alcoholic liver disease. Alcohol Clin Exp Res. 27(11):1765-1772, 2003.
RC. The epidemiology of dual diagnosis. Biol Psychiatry. 56(10):730-737,
BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use
disorders and independent mood and anxiety disorders: Results from the National
Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry.
DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): A review
of recent research. Alcohol Clin Exp Res. 26(2):272-279, 2002.
KA, Boyd-Wickizer J, Powell SH, Burman ML. Alcohol screening questionnaires in
women: A critical review. JAMA. 280(2):166-171, 1998.
DA, Reid MC, O’Connor PG. Screening for alcohol problems in primary care:
A systematic review. Arch Intern Med. 160(13):1977-1989, 2000.
T, Colby SM, Barnett NP, Rohsenow DJ, Spirito A, Monti PM. Screening adolescents
for problem drinking: Performance of brief screens against DSM-IV alcohol diagnoses.
J Stud Alcohol. 61(4):579-587, 2000.
HR, Armeli S, Tennen H, et al. Targeted naltrexone for early problem drinkers.
J Clin Psychopharmacol. 23(3):294-304, 2003.
JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting
injectable naltrexone for alcohol dependence: A randomized controlled trial. JAMA,
C, Angeles M, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate
in the treatment of alcohol dependence: A systematic review. Addiction.
M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: A meta-analysis
of randomized controlled trials. Int J Neuropsychopharmacol. 8(2):267-280,
K, Lehert P, Morgan MY. The efficacy of acamprosate in the maintenance of abstinence
in alcohol-dependent individuals: Results of a metaanalysis. Alcohol Clin
Exp Res. 28(1):51-63, 2004.
RF, O’Malley SS, Ciraulo DA, et al., for the COMBINE Study Research Group.
Combined pharmacotherapies and behavioral interventions for alcohol dependence:
The COMBINE study: A randomized controlled trial. JAMA. 295(17):2003-
BJ, Goodman AM, Chabac S, Lehert P. Effect of oral acamprosate on abstinence in
patients with alcohol dependence in a double-blind, placebo-controlled trial:
The role of patient motivation. J Psychiatr Res. 40(5):383-393, 2006.
R, Arlinde C, Sommer W, Heilig M. Longlasting increase in voluntary ethanol consumption
and transcriptional regulation in the rat brain after intermittent exposure to
alcohol. FASEB J. 16(1):27-35, 2002.
BJ, Ownby RL. Acamprosate for the treatment of alcohol dependence: A review of
double-blind, placebo-controlled trials. CNS Spectrums. 5:58-69, 2000.
RK, Gordis E. Does disulfiram have a role in alcoholism treatment today? Addiction.
JP, Litten RZ. Techniques to enhance compliance with disulfiram. Alcohol Clin
Exp Res. 16(6):1035-1041, 1992.
and brief intervention for alcohol problems. In: The Tenth Special Report
to the U.S. Congress on Alcohol and Health. Rockville, MD: National Institute
on Alcohol Abuse and Alcoholism; 2000:429-443. NIH Publication No. 00-1583.
K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, for the Ambulatory Care Quality
Improvement Project (ACQUIP). The AUDIT alcohol consumption questions (AUDIT-C):
An effective brief screening test for problem drinking. Alcohol Use Disorders
Identification Test. Arch Intern Med. 158(16):1789-1795, 1998.
EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions
in primary care to reduce risky/harmful alcohol use by adults: A summary of the
evidence for the U.S. Preventive Services Task Force. Ann Intern Med.
DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders
Identification Test (AUDIT-C) in screening for alcohol use disorders and risk
drinking in the U.S. general population. Alcohol Clin Exp Res. 29(5):844-854,
DA, Grant BF, Stinson FS, Chou PS. Psychopathology associated with drinking and
alcohol use disorders in the college and general adult populations. Drug Alcohol
Depend. 77(2):139-150, 2005.
KJ, Rimm EB. Alcohol’s effects on the risk for coronary heart disease. Alcohol
Res Health. 25(4):255- 261, 2001.
consumption among women who are pregnant or who might become pregnant—US,
2002. MMWR Morb Mortal Wkly Rep. 53(50):1178-1181, 2004.
estimate of 2,000 to 8,000 infants born with fetal alcohol syndrome (FAS) is derived
by multiplying 4 million U.S. births annually by an estimated 0.5 to 2 percent
prevalence of FAS in the general U.S. population. Sources: (1) National Center
for Health Statistics. Births, marriages, divorces, and deaths: Provisional data
for 2001. National Vital Statistics Reports; 2002:50(14); and May PA,
Gossage JP. Estimating the prevalence of fetal alcohol syndrome: A summary. Alcohol
Res Health. 25(3):159-167, 2001.
MATCH Research Group. Matching alcoholism treatments to client heterogeneity:
Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 22(6):1300-1311,
MF. Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based
practice guideline. American Society of Addiction Medicine Working Group on Pharmacological
Management of Alcohol Withdrawal. JAMA. 278(2):144-151, 1997.
MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium:
An evidence-based practice guideline. Arch Intern Med. 164(13):1405-1412,
HL, de Bock GH. The value of laboratory tests for the screening and recognition
of alcohol abuse in primary care patients. J Fam Pract. 37:268-276, 1993.
Preventive Services Task Force. Guide to Clinical Preventive Services.
2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism:
A systematic review. Alcohol. 19(3):261-271, 1999.
WR, Walters ST, Bennett ME. How effective is alcohol treatment in the United States?
J Stud Alcohol. 62:211-220, 2001.
AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical
illness: Implications for treatment, insurance, and outcomes evaluation. JAMA.
DA, Grant BF, Stinson FS, Chou PS, Huang B, Ruan WJ. Recovery from DSM-IV alcohol
dependence: United States, 2001-2002. Addiction. 100(3):281-292, 2005.
| Table of Contents